Safe Healthcare | Hosted by CDC’s Division of Healthcare Quality PromotionSafe Healthcare | Blogs | CDC

Safe Healthcare | Hosted by CDC’s Division of Healthcare Quality PromotionSafe Healthcare | Blogs | CDC



Marked Geographic Variation of CRE in Tennessee and Implications for Prevention

Today, on CDC's Safe Healthcare blog, Marion Kainer, MD, MPH, FRACP, FSHEA, Director of the Healthcare-Associated Infections and Antimicrobial Resistance Program at the Tennessee Department of Health, discusses the geographic variation of Carbapenem-resistant Enterobacteriaceae (CRE) in the state of Tennessee and the implications for prevention. The post kicks off a three-part series related to CDC’s August 2015 Vital Signs: Making Health Care Safer: Stop Spread of Antibiotic Resistance.

The Vital Signs report includes mathematical modeling that projects increases in drug-resistant infections andClostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. While the coordinated approach this Vital Signs report describes is a forward-looking approach, some states are already implementing the response in a variety of different ways. This three-part blog serieswill spotlight the current efforts in Tennessee, Illinois and Wisconsin.

Learn more and join the conversation at: http://blogs.cdc.gov/safehealthcare/?p=4572. Stay tuned for parts 2 and 3 of the blog series on August 12 and 13.

Hosted by CDC’s Division of Healthcare Quality Promotion

Marked Geographic Variation of CRE in Tennessee and Implications for Prevention (Part 1 of a 3-part Series on the August 2015 Vital Signs: Making Health Care Safer: Stop Spread of Antibiotic Resistance)

The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria, Read More >

Posted on August 11, 2015 by CDC's Safe Healthcare BlogLeave a comment

Categories Antibiotic use, Antimicrobial Resistance, Clostridium difficile, Healthcare-associated infections

---

CDC Modeling Shows Safe Health Care Means Coordination

CDC’s Dr. Scott Fridkin Senior Advisor for Antibiotic Resistance in Health care Today CDC released its latest Vital Signs report, which includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. The report includes recommendations that would impact how health care Read More >

Posted on August 4, 2015 by CDC's Safe Healthcare BlogLeave a comment

Categories Antibiotic use, Antimicrobial Resistance, Clostridium difficile, Healthcare-associated infections

---

Consumer Reports looks at how well hospitals prevent common infections

A new analysis finds big differences in hospital performance against C. diff and MRSA infections. Guest Author: Teresa Carr Senior Editor, Best Buy Drugs Consumer Reports An estimated one in 25 patients develops at least one infection while in the hospital, according to the Centers for Disease Control and Prevention (CDC). But that number is Read More >

Posted on July 29, 2015 by DHQPLeave a comment

Categories HAI Guidelines, Healthcare-associated infections, Infection Control, Injection Safety, Long Term Care (LTC)

---

Point Is Protection: Safety First for Oncology Health Care Professionals and Our Patients

Guest Author: Michele E. Gaguski MSN RN AOCN CHPN APN-C As an oncology nurse, I see the quick pace in which cancer treatment modalities continue to advance.  I attribute this rapid advancement to several factors: new medications have gained approval chemotherapy regimens involving multiple medications and administration methods have become mainstream clinical trials continue to Read More >

Posted on July 16, 2015 by CDC's Safe Healthcare Blog1 Comment

Categories Healthcare-associated infections, Infection Control, Injection Safety, Patient Safety

---

Tackling Injection Safety Worldwide: WHO’s Safe Injection Global Network

Guest Author: Dr. Evelyn McKnight, President and Co-Founder of HONOReform How thrilling to be part of a global effort to advance injection safety! It was a rewarding moment when we entered the doors of the World Health Organization in Geneva, Switzerland in February to participate in meetings of the Safe Injection Global Network (SIGN). We Read More >

Posted on July 10, 2015 by CDC's Safe Healthcare Blog6 Comments

Categories Healthcare-associated infections, Injection Safety, Patient Safety